Adverse clinical events for the whole cohort as well as by Fried frailty status occurring at a mean follow-up of 107 days
| Fried frailty phenotype | |||||
| Total cohort (n=150) | Not frail (n=19) | Pre-frail (n=89) | Frail (n=42) | P value | |
| MACE* | 37 (24.7%) | 8 (42.1%) | 16 (18.0%) | 13 (31.0%) | 0.31 |
| Death | 14 (9.3%) | 2 (10.5%) | 5 (5.6%) | 7 (16.7%) | 0.13 |
| Myocardial infarction | 8 (5.3%) | 2 (10.5%) | 3 (3.4%) | 3 (7.1%) | 0.37 |
| CVA | 3 (2.0%) | 1 (5.3%) | 1 (1.1%) | 1 (2.4%) | 0.49 |
| TIA | 5 (3.3%) | 1 (5.3%) | 3 (3.4%) | 1 (2.4%) | 0.84 |
| Major bleed | 12 (8.0%) | 3 (15.85) | 7 (7.9%) | 2 (4.8%) | 0.34 |
| AKI | 26 (17.3%) | 3 (15.8%) | 10 (11.2%) | 13 (31.0%) | 0.02 |
*MACE was defined as the composite of death, myocardial infarction, stroke or major bleeding.
AKI, acute kidney injury; CVA, cerebrovascular accident; MACE, major adverse cardiac event; TIA, transient ischaemic event.